Acasti Pharma (ACST) Stock Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free ACST Stock Alerts $2.84 -0.11 (-3.73%) (As of 05:13 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Acasti Pharma Stock Price Performance5 Day Performance-2.64%1 Month Performance-13.24%3 Month Performance+25.00%6 Month Performance+19.43%Year-To-Date Performance+2.08%1 Year Performance+9.80% Receive ACST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. ACST Stock Chart for Tuesday, May, 7, 2024 ACST Chart by TradingView Acasti Pharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/06/2024$2.96$2.95-0.34%$3.01$2.8811,882 shs$27.73 million05/03/2024$3.03$2.96-2.31%$3.08$2.8813,180 shs$27.82 million05/02/2024$2.84$3.03+6.69%$3.11$2.8516,554 shs$28.48 million05/01/2024$2.78$2.84+2.16%$2.90$2.704,500 shs$26.70 million04/30/2024$2.68$2.78+3.73%$3.05$2.6510,382 shs$26.13 million04/29/2024$2.90$2.68-7.59%$2.84$2.666,860 shs$25.19 million Get the Latest News and Ratings for ACST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. 04/26/2024$2.93$2.90-0.97%$3.13$2.773,826 shs$27.26 million04/25/2024$2.94$2.93-0.39%$2.93$2.862,465 shs$27.53 million04/24/2024$2.88$2.94+2.08%$3.16$2.878,422 shs$27.63 million04/23/2024$2.85$2.88+1.05%$2.88$2.854,477 shs$27.07 million04/22/2024$2.87$2.85-0.70%$2.91$2.819,839 shs$26.79 million04/19/2024$3.06$2.87-6.21%$3.08$2.8719,767 shs$26.98 million04/18/2024$3.17$3.06-3.47%$3.17$3.069,712 shs$28.76 million04/17/2024$3.37$3.17-5.93%$3.31$3.1616,794 shs$29.80 million04/16/2024$3.36$3.37+0.30%$3.39$3.307,377 shs$31.68 million04/15/2024$3.41$3.36-1.32%$3.41$3.3221,644 shs$31.58 million04/12/2024$3.40$3.41+0.15%$3.42$3.315,836 shs$32.01 million04/11/2024$3.40$3.40$3.40$3.3026,875 shs$31.96 million04/10/2024$3.40$3.40$3.40$3.2621,307 shs$31.96 million04/09/2024$3.40$3.40$3.41$3.3216,990 shs$31.96 million04/08/2024$3.40$3.40$3.43$3.329,106 shs$31.96 million04/05/2024$3.40$3.40$3.40$3.335,415 shs$31.96 million04/04/2024$3.38$3.40+0.59%$3.46$3.3435,967 shs$31.96 million04/03/2024$3.43$3.38-1.46%$3.41$3.3534,601 shs$31.77 million04/02/2024$3.45$3.43-0.58%$3.50$3.3925,125 shs$32.24 million04/01/2024$3.43$3.45+0.73%$3.45$3.2928,550 shs$32.43 million03/29/2024$3.45$3.43-0.72%$3.43$3.3733,132 shs$32.20 million03/28/2024$3.40$3.45+1.47%$3.45$3.3733,131 shs$32.43 million03/27/2024$3.40$3.40$3.44$3.37224,147 shs$31.96 million03/26/2024$3.41$3.40-0.29%$3.44$3.3722,567 shs$31.96 million03/25/2024$3.40$3.41+0.29%$3.42$3.3817,025 shs$32.05 million03/22/2024$3.42$3.41-0.29%$3.42$3.3819,686 shs$32.05 million03/21/2024$3.40$3.42+0.59%$3.45$3.3730,588 shs$32.15 million03/20/2024$3.40$3.40$3.40$3.3317,518 shs$31.96 million03/19/2024$3.40$3.40$3.41$3.3423,872 shs$31.96 million03/18/2024$3.38$3.40+0.59%$3.41$3.3616,140 shs$31.96 million03/15/2024$3.41$3.41$3.43$3.3611,977 shs$32.05 million03/14/2024$3.40$3.41+0.29%$3.45$3.3838,993 shs$32.05 million03/13/2024$3.43$3.40-0.87%$3.41$3.3318,481 shs$31.96 million03/12/2024$3.35$3.43+2.39%$3.45$3.3448,519 shs$32.24 millionThe A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself.03/11/2024$3.40$3.35-1.47%$3.36$3.2624,876 shs$31.49 million03/08/2024$3.40$3.40$3.44$3.3015,310 shs$31.96 million03/07/2024$3.45$3.40-1.45%$3.45$3.3121,168 shs$31.96 million03/06/2024$3.40$3.45+1.47%$3.49$3.3416,848 shs$32.43 million03/05/2024$3.44$3.40-1.16%$3.46$3.3243,075 shs$31.96 million03/04/2024$3.44$3.44+0.15%$3.48$3.3930,890 shs$32.34 million03/01/2024$3.34$3.48+4.19%$3.48$3.3611,422 shs$32.71 million02/29/2024$3.40$3.34-1.76%$3.48$3.3015,003 shs$31.40 million02/28/2024$3.33$3.40+2.10%$3.48$3.309,566 shs$31.96 million02/27/2024$3.34$3.33-0.30%$3.40$3.3011,681 shs$31.30 million02/26/2024$3.35$3.34-0.30%$3.37$3.2317,896 shs$31.39 million02/23/2024$3.39$3.35-1.18%$3.49$3.3119,394 shs$31.49 million02/22/2024$3.34$3.39+1.50%$3.59$3.3436,661 shs$31.87 million02/21/2024$3.11$3.34+7.40%$3.35$3.0454,204 shs$31.40 million02/20/2024$3.30$3.11-5.76%$3.35$3.1063,113 shs$29.23 million02/19/2024$3.30$3.30$3.30$2.9962,600 shs$31.02 million02/16/2024$3.06$3.30+7.84%$3.30$2.9962,364 shs$31.02 million02/15/2024$2.64$3.06+15.91%$3.06$2.5989,703 shs$28.76 million02/14/2024$2.45$2.64+7.76%$2.80$2.5222,915 shs$24.82 million02/13/2024$2.61$2.45-6.13%$2.72$2.4241,826 shs$23.03 million02/12/2024$2.45$2.61+6.53%$2.80$2.4164,157 shs$24.53 million02/09/2024$2.45$2.50+2.04%$2.50$2.438,231 shs$23.50 million02/08/2024$2.36$2.45+3.81%$2.48$2.386,014 shs$23.03 million02/07/2024$2.33$2.36+1.29%$2.50$2.3418,443 shs$22.18 million02/06/2024$2.30$2.33+1.30%$2.38$2.296,087 shs$21.90 million Related Companies: UBX Stock Price Chart FBRX Stock Price Chart NRXP Stock Price Chart SNSE Stock Price Chart ITRM Stock Price Chart LPCN Stock Price Chart BFRG Stock Price Chart APRE Stock Price Chart BIOR Stock Price Chart LUMO Stock Price Chart Receive ACST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACST) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden replacement revealed?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acasti Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.